Advertisement
U.S. Markets close in 28 mins

Gland Pharma Limited (GLAND.BO)

BSE - BSE Real Time Price. Currency in INR
1,647.10-29.55 (-1.76%)
At close: 03:29PM IST
Currency in INR

Valuation Measures4

Market Cap (intraday) 276.01B
Enterprise Value 260.34B
Trailing P/E 38.24
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.73
Price/Book (mrq)3.17
Enterprise Value/Revenue 4.61
Enterprise Value/EBITDA 17.37

Trading Information

Stock Price History

Beta (5Y Monthly) 0.30
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32,220.95
52 Week Low 31,477.00
50-Day Moving Average 31,835.90
200-Day Moving Average 31,860.79

Share Statistics

Avg Vol (3 month) 312.4k
Avg Vol (10 day) 36.2k
Shares Outstanding 5164.75M
Implied Shares Outstanding 6N/A
Float 873.14M
% Held by Insiders 151.84%
% Held by Institutions 137.35%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 420
Forward Annual Dividend Yield 41.19%
Trailing Annual Dividend Rate 320.00
Trailing Annual Dividend Yield 31.19%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Aug 16, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 12.33%
Operating Margin (ttm)12.30%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)58.58B
Revenue Per Share (ttm)355.63
Quarterly Revenue Growth (yoy)16.00%
Gross Profit (ttm)N/A
EBITDA 13.26B
Net Income Avi to Common (ttm)7.22B
Diluted EPS (ttm)43.76
Quarterly Earnings Growth (yoy)-25.90%

Balance Sheet

Total Cash (mrq)18.39B
Total Cash Per Share (mrq)111.7
Total Debt (mrq)3.72B
Total Debt/Equity (mrq)4.27
Current Ratio (mrq)N/A
Book Value Per Share (mrq)529.54

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A